title: Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.
abstract: BACKGROUND
  TNFalpha seems to contribute to inflammation and malnutrition in Crohn's disease (CD) patients. In CD patients, the comparative effects on nutritional status of infliximab and traditional therapy have not yet been determined. The aim of our study was to assess the effects of infliximab as compared with those of standard therapy on nutritional status, disease activity, resting energy expenditure (REE), and food intake in CD children and adolescents.
  
  
  METHODS
  From September 1999 to September 2005, all CD patients treated with infliximab (group A) were reviewed and matched with CD patients treated with traditional therapy (mesalazine and azathioprine) (group B).
  
  
  RESULTS
  Fourteen CD patients from group A and 14 from group B were included; median interval before follow-up investigation was 10 months. Baseline and final values of weight, height, body mass index (BMI), pediatric CD activity index (pCDAI), REE, and food intake were studied. In treated patients, but not in control group, mean baseline weight (kg) and BMI values, 39.7 +/- 13.1 and 17.9 +/- 3.3, respectively, were significantly lower than their final values 42.6 +/- 13.2 and 18.9 +/- 3.1, and median pCDAI values 23.5 were significantly higher than their final values 10 (P < 0.05). Significant changes in height, REE, and food intake were not found in either group.
  
  
  CONCLUSIONS
  In pediatric CD patients, infliximab seems to impact positively on the nutritional status as demonstrated by the improvement in weight and BMI, but not in linear growth; effects on nutritional status seem to be due to amelioration of disease activity, rather than to REE reduction or food intake increase.
authors.affiliation: Gastroenterology and Nutrition Unit, Bambino Gesù Children's Hospital, Piazza S. Onofrio, 4-00165, Rome, Italy. diamanti@opbg.net
authors.forename: A
authors.initials: A
authors.lastname: Diamanti
authors.forename: M S
authors.initials: MS
authors.lastname: Basso
authors.forename: M
authors.initials: M
authors.lastname: Gambarara
authors.forename: B
authors.initials: B
authors.lastname: Papadatou
authors.forename: F
authors.initials: F
authors.lastname: Bracci
authors.forename: C
authors.initials: C
authors.lastname: Noto
authors.forename: M
authors.initials: M
authors.lastname: Castro
mesh_terms: D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D001827:Body Height; D015992:Body Mass Index; D001835:Body Weight; D016022:Case-Control Studies; D002648:Child; D003424:Crohn Disease / Q000188:drug therapy*; D004435:Eating; D004734:Energy Metabolism; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D019804:Mesalamine / Q000627:therapeutic use; D009752:Nutritional Status; D012189:Retrospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D019804:Mesalamine; D000069285:Infliximab; D001379:Azathioprine
references.citation: J Pediatr Gastroenterol Nutr. 2003 May;36(5):632-6
references.pmid: 12717087
references.citation: Gastroenterology. 2000 Oct;119(4):895-902
references.pmid: 11040176
references.citation: J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):15-27
references.pmid: 15187775
references.citation: Am J Clin Nutr. 1991 Jan;53(1):161-5
references.pmid: 1984342
references.citation: N Engl J Med. 1997 Aug 7;337(6):396-407
references.pmid: 9241130
references.citation: Dig Liver Dis. 2004 May;36(5):342-7
references.pmid: 15191204
references.citation: Hum Nutr Clin Nutr. 1985;39 Suppl 1:5-41
references.pmid: 4044297
references.citation: Clin Nutr. 2005 Dec;24(6):1047-55
references.pmid: 16198449
references.citation: J Pediatr Gastroenterol Nutr. 1991 May;12(4):439-47
references.pmid: 1678008
references.citation: Horm Res. 2002;58 Suppl 1:11-5
references.pmid: 12373007
references.citation: J Clin Endocrinol Metab. 2005 Jun;90(6):3510-6
references.pmid: 15784704
references.citation: BMC Pediatr. 2004 Mar 12;4:6
references.pmid: 15113440
references.citation: Inflamm Bowel Dis. 2003 Jan;9(1):34-58
references.pmid: 12656136
references.citation: Gastroenterology. 2007 Mar;132(3):863-73; quiz 1165-6
references.pmid: 17324398
references.citation: J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):46-52
references.pmid: 15187780
references.citation: J Pediatr Gastroenterol Nutr. 1996 Jul;23(1):13-9
references.pmid: 8811517
references.citation: Gut. 1993 Jul;34(7):939-43
references.pmid: 8344582
references.citation: J Pediatr. 2002 Jan;140(1):75-80
references.pmid: 11815767
references.citation: J Pediatr. 2002 Jul;141(1):64-70
references.pmid: 12091853
references.citation: Inflamm Bowel Dis. 2007 Apr;13(4):424-30
references.pmid: 17206672
references.citation: Gut. 2004 Dec;53(12):1817-24
references.pmid: 15542521
references.citation: J Pediatr Gastroenterol Nutr. 2001 Jul;33(1):75-80
references.pmid: 11479412
references.citation: Nutrition. 1998 Jan;14(1):124-9
references.pmid: 9437698
references.citation: N Engl J Med. 1995 Feb 2;332(5):305-11
references.pmid: 7816067
references.citation: J Clin Invest. 2004 Nov;114(9):1272-80
references.pmid: 15520859
references.citation: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003873
references.pmid: 16034910
references.citation: Am J Clin Nutr. 1991 Jul;54(1):26-9
references.pmid: 2058583
references.citation: Gut. 1997 Aug;41(2):203-8
references.pmid: 9301499
references.citation: J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74
references.pmid: 17460505
references.citation: Dig Liver Dis. 2006 Jun;38(6):381-7
references.pmid: 16301010
references.citation: Ann Rheum Dis. 2006 Aug;65(8):1044-9
references.pmid: 16449314
references.citation: Am J Gastroenterol. 2003 Apr;98(4):833-8
references.pmid: 12738464
references.citation: Gut. 2004 Dec;53(12):1724-5
references.pmid: 15542502
references.citation: Acta Paediatr Suppl. 1999 Feb;88(428):89-92
references.pmid: 10102061
references.citation: J Pediatr Gastroenterol Nutr. 2005 Jul;41(1):1-7
references.pmid: 15990620
references.citation: Horm Res. 2002;58 Suppl 1:7-10
references.pmid: 12373006